Do you have questions about the latest in MS research, symptom management, clinical care options and more? Get your MS questions answered by Dr. Andrew Wolf of the Rocky Mountain MS Center.
Conversations on MS is an audience-directed discussion -- so you should come ready to ask questions and participate! This is a unique opportunity to ask questions and explore information there usually isn't time for during a clinic visit with your neurologist.
ASK YOUR QUESTIONS IN ADVANCE
Ask questions ahead of time at the prompt after you register, or by emailing us at education@mscenter.org.
JOIN US IN PERSON
We'll be live and in-person in the Durango Public Library & Durango Botanic Gardens(1900 E 3rd Ave, Durango, CO 81301).
To join us, make sure you select the "IN PERSON" ticket option when you register. We follow up with everything you need to know to attend in emails as the date approaches.
JOIN US ONLINE
This Online Broadcast will be conducted via Zoom, all registrants who select the "ONLINE VIA ZOOM" ticket option will receive a link to the Zoom meeting in the days leading up to the session -- please watch your email. The meeting room will open a few minutes before the scheduled start of the event.
- You must have access to a computer or mobile device capable of joining a Zoom session to participate. For more info on Zoom visit www.zoom.us. Registered participants will receive an email one day prior to the event with details about how to join the Zoom meeting.
- PLEASE NOTE: This session will be recorded and archived for viewing by others. Online attendees who do not wish to be recorded may participate anonymously by turning off their video and audio, and interacting only via text chat.
ABOUT THE PRESENTER
Dr. Andrew Wolf attended medical school at the University of Colorado Denver School of Medicine, and completed Residency and Fellowships at the University of Colorado. His research interests are focused on improving the treatment of patients with multiple sclerosis and other inflammatory diseases of the central nervous system. Current projects include developing digital and blood biomarkers to detect worsening in multiple sclerosis patients, characterizing clinical outcomes of neuroinvasive West Nile virus infection in patients on anti-CD20 treatments, and understanding the risks of immune checkpoint inhibitor use in patients with neuroimmunological disease. He is also interested in the acute management of demyelinating diseases and optimizing inpatient to outpatient care transitions.
The Rocky Mountain MS Center's Conversations on MS series is made possible in part by support from Biogen and Genentech.
